Global Alpha Emitters Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Alpha Emitters Market Research Report 2024
Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues than beta-emitters and this particle action has caught the market attention.
According to MRAResearch’s new survey, global Alpha Emitters market is projected to reach US$ 1946.2 million in 2033, increasing from US$ 502.8 million in 2022, with the CAGR of 20.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alpha Emitters market research.
The market for alpha-emitters in the United States is growing rapidly. The United States accounted for the largest global market share in 2017. The high-end research trend in the United States, coupled with high investments in healthcare research and abundant knowledge in cancer research, is the key factor propelling the growth of the market in this country.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Alpha Emitters market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bayer
Alpha Tau Medical
IBA RadioPharma
Actinium Pharmaceuticals
Telix Pharmaceuticals
RadioMedix
Fusion Pharmaceuticals
Segment by Type
Terbium (Tb-149)
Astatine (At-211)
Bismuth (Bi-212)
Actinium (Ac-225)
Radium (Ra-223)
Lead (Pb-212)
Bismuth (Bi-213)
Hospitals
Medical Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Alpha Emitters report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Alpha Emitters market is projected to reach US$ 1946.2 million in 2033, increasing from US$ 502.8 million in 2022, with the CAGR of 20.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alpha Emitters market research.
The market for alpha-emitters in the United States is growing rapidly. The United States accounted for the largest global market share in 2017. The high-end research trend in the United States, coupled with high investments in healthcare research and abundant knowledge in cancer research, is the key factor propelling the growth of the market in this country.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Alpha Emitters market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bayer
Alpha Tau Medical
IBA RadioPharma
Actinium Pharmaceuticals
Telix Pharmaceuticals
RadioMedix
Fusion Pharmaceuticals
Segment by Type
Terbium (Tb-149)
Astatine (At-211)
Bismuth (Bi-212)
Actinium (Ac-225)
Radium (Ra-223)
Lead (Pb-212)
Bismuth (Bi-213)
Segment by Application
Hospitals
Medical Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Alpha Emitters report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source